bims-auttor Biomed News
on Autophagy and mTOR
Issue of 2026–11–15
25 papers selected by
Viktor Korolchuk, Newcastle University



  1. Mol Med Rep. 2027 Jan;pii: 11. [Epub ahead of print]35(1):
      Parkinson's disease (PD) is the second most common neurodegenerative disorder, characterized by the progressive loss of dopaminergic neurons in the substantia nigra and the accumulation of misfolded α‑synuclein forming Lewy bodies. Emerging evidence highlights mitochondrial dysfunction as an important and early event in PD pathogenesis. Among the key regulators of mitochondrial quality control, PTEN‑induced kinase 1 (PINK1) plays a pivotal role by initiating mitophagy, the selective clearance of damaged mitochondria. Under physiological conditions, PINK1 is rapidly degraded, whereas mitochondrial depolarization stabilizes PINK1 on the outer mitochondrial membrane, where it recruits and activates Parkin, an E3 ubiquitin ligase, to promote mitophagy. Loss‑of‑function mutations in PINK1 also disrupt this process, leading to the accumulation of dysfunctional mitochondria, oxidative stress, abnormal calcium homeostasis and neuronal apoptosis. Furthermore, PINK1 deficiency has been shown to exacerbate α‑synuclein aggregation, impair synaptic transmission and activate neuroinflammatory pathways, collectively accelerating dopaminergic neurodegeneration. Therapeutic strategies aimed at restoring or enhancing PINK1‑mediated mitophagy through pharmacological activation, gene delivery or modulation of parallel pathways‑represent a promising avenue for PD intervention. Continued elucidation of the molecular functions of PINK1 will provide critical insights into mitochondrial homeostasis and novel therapeutic targets for PD.
    Keywords:  PINK1; Parkinson's disease; mitochondrial autophagy
    DOI:  https://doi.org/10.3892/mmr.2026.14069
  2. bioRxiv. 2026 Oct 20. pii: 2026.10.14.758959. [Epub ahead of print]
      Autophagy is a conserved cellular recycling pathway linked to longevity and regulated by autophagy-related (ATG) protein. Many of these proteins serve a key function in ATG8 lipidation onto autophagosomal membranes, a step that precedes subsequent lysosomal degradation. Recently, mammalian ATG16L1, a member of ATG8 lipidation machinery, have been shown to also direct ATG8 lipidation onto other membranes via its C-terminal WD40 domain in acutely stressed cells. However, whether such non-canonical functions of the ATG16L1 WD40 domain influence longevity remain largely unknown. Here, we endogenously deleted the WD40 domain of atg-16.2 , the C. elegans ortholog of ATG16L1 , and examined autophagy, healthspan and longevity. The ATG-16.2 WD40 domain was dispensable for healthspan measures and for ATG8 lipidation in whole animals and neurons but was required for autophagic flux across all major tissues examined. Notably, the ATG-16.2 WD40 domain was also critical in limiting lysosomal membrane damage after acute heat stress. Because long-lived C. elegans mutants are typically heat resistant, we asked whether this lysosomal function supported their thermotolerance and found the WD40 domain to be selectively required for thermotolerance induced by germline removal, but not by reduced insulin/IGF-1 signaling or dietary restriction. In germline-less animals, loss of the ATG-16.2 WD40 domain reduced nuclear TFEB/HLH-30, reduced neuronal autophagic degradation, altered neuronal lysosomal pH, and sensitized animals to heat-induced lysosomal damage. Collectively, these findings establish the ATG16 WD40 domain as a regulator of autophagic degradation and lysosomal integrity in vivo, and show that this role is associated with longevity in a pathway-selective manner.
    Highlights: The ATG-16.2 WD40 domain is dispensable for C. elegans healthspan but required for autophagic degradation in vivo The WD40 domain limits lysosomal membrane damage after acute heat stress in vivo The WD40 domain is selectively required for thermotolerance and longevity induced by germline removal ( glp-1/NotchR mutation) Elevated neuronal lysosomal pH in germline-less animals requires the WD40 domain.
    DOI:  https://doi.org/10.64898/2026.10.14.758959
  3. J Biol Chem. 2026 Nov 13. pii: S0021-9258(26)02625-6. [Epub ahead of print] 113753
      The mitochondrial kinase PTEN-induced kinase 1 (PINK1) initiates mitophagy in response to mitochondrial damage, yet mechanisms that constrain its activation under basal conditions remain incompletely defined. Here, we identify a non-canonical SUMO 2/3 modification of PINK1 that suppresses basal mitophagy. We show that the mitochondrial E3 ligase mitochondrial-anchored protein ligase (MAPL/MUL1) promotes PINK1 SUMO-2/3 modification, while MAPL depletion reduces SUMOylation and enhances basal mitophagy. Targeted deSUMOylation augments mitophagy. These findings reveal a novel SUMO-based checkpoint for basal PINK1 activation and mitochondrial quality control.
    Keywords:  MAPL; PINK1; SUMO-2/3; SUMOylation; mitochondrial quality control; mitophagy
    DOI:  https://doi.org/10.1016/j.jbc.2026.113753
  4. Res Sq. 2026 Oct 20. pii: rs.3.rs-11310455. [Epub ahead of print]
      Damaged mitochondria are cleared by PINK1-Parkin mitophagy, but the pathway is incompletely understood in vivo. Here, we developed MitoFLUX-EM, combining electron microscopy with nanoscale ¹⁵N isotope tracing to resolve the temporal sequence of mitophagy intermediates in vivo, and applied it to a cardiomyopathy mouse model (CHCHD10 S59L) with high PINK1-dependent mitophagy. Unexpectedly, we found that damaged mitochondria are directly captured by pre-existing mitolysosomes, resulting in multisegmented mitolysosomes that sequestered as many as 33 mitochondria at distinct stages of ultrastructural degradation. Autophagosomal-like membranes arising from the mitolysosomes preferentially engaged the intact outer membrane of damaged mitochondria and neither protein removal nor rupture of the outer membrane was required for mitophagy, contrary to prior models. Pink1 loss disrupted this pathway, causing accumulation of aggregates within mitochondria and reduced survival. These findings reveal that PINK1-dependent mitophagy proceeds through a novel form of microautophagy to safeguard cardiac mitochondrial quality in vivo and establish MitoFLUX-EM as a platform for resolving organelle turnover.
    DOI:  https://doi.org/10.21203/rs.3.rs-11310455/v1
  5. Nat Rev Mol Cell Biol. 2026 Nov 09.
      Timely removal of defective or superfluous cellular components, including misfolded proteins, aberrant protein complexes and damaged organelles, is essential for maintaining cellular homeostasis and adaptation to stress. This process is controlled by an intricate interplay between two principal degradation systems, the ubiquitin-proteasome system and autophagy, which together mediate the recognition, selection and elimination of diverse substrates. In this Review, we discuss how proteins and organelles are dynamically partitioned between these catabolic pathways in response to physiological demands, cellular stress and damage. We highlight the mechanisms of substrate sequestration, the spatial and temporal organization of the degradation machineries and the compensatory responses that preserve proteostasis when one pathway is compromised, including the coordination with the unfolded protein response. We also examine how selective pathways such as endoplasmic reticulum phagy and mitophagy remodel or eliminate damaged organelles. Recent advances in electron tomography have revealed the ultrastructural basis of these networks, providing insights into their architecture and dynamics. Finally, we discuss how defects in these degradation systems contribute to ageing, cancer, neurodegeneration and other pathologies.
    DOI:  https://doi.org/10.1038/s41580-026-01037-0
  6. JCI Insight. 2026 Nov 09. pii: e207890. [Epub ahead of print]11(21):
      Cellular senescence, a hallmark of aging, is accompanied by a striking expansion of the cell's lysosomal compartment, yet the pathway leading to increased lysosomal content remains unresolved. Here, we demonstrate that the master lysosomal transcriptional regulator TFEB is activated during senescence through a pathway that involves conjugation of ATG8 onto single membranes (CASM). Using various senescence inducers, we show that senescence induction triggers robust TFEB nuclear translocation and upregulation of TFEB target genes. In contrast, inhibition of the core CASM machinery by CRISPR-mediated deletion of either ATG16L1, ATG12, or ATG5 markedly reduced senescence-induced TFEB nuclear translocation. In ATG16L1-KO cells, reconstitution with WT ATG16L1 but not the CASM-defective ATG16L1F467A mutant restored both ATG8 lipidation on the lysosomal surface and TFEB activation. Moreover, expression of the Salmonella effector protein SopF, a previously described specific CASM inhibitor, similarly blocked senescence-induced TFEB translocation. Functionally, upon stress, CASM-deficient cells exhibited a pronounced shift away from senescence and toward a cell death fate, a phenotype reversed by expressing a constitutively active form of TFEB. Together, these findings identify CASM-dependent TFEB activation as an essential mechanism enabling senescence-associated lysosomal expansion and suggest that lysosomal capacity modulates cell fate decisions in the aftermath of acute stress.
    Keywords:  Aging; Cell biology; Lysosomes
    DOI:  https://doi.org/10.1172/jci.insight.207890
  7. Dev Cell. 2026 Nov 11. pii: S1534-5807(26)00395-3. [Epub ahead of print]61(11): 2193-2212.e8
      p53 protects against the initiation and progression of cancers, but the mechanisms underlying this function remain incompletely understood. Chaperone-mediated autophagy (CMA) is a form of autophagy unique in vertebrates, yet its regulation and function are unclear. Here, we demonstrate that p53 functions as a central activator of CMA, integrating stress signals to regulate this selective autophagic pathway. Mechanistically, the energy sensor AMP-activated protein kinase (AMPK) inhibits CMA by preventing oligomerization of its receptor LAMP2A. Cytoplasmic p53 interacts with AMPK and relieves this inhibition. By activating CMA, p53 promotes lysosomal degradation of isocitrate dehydrogenases IDH1 and IDH2, thereby reducing intracellular α-ketoglutarate levels, inhibiting reductive glutamine metabolism, and suppressing growth of lung and liver cancers. Tumor-associated p53 mutants fail to promote CMA, whereas oncogenic IDH1/2 mutants evade CMA-mediated degradation. These results suggest that CMA activation may be a fundamental component of p53 function, through which it modulates metabolism and inhibits oncogenic growth.
    Keywords:  AMPK; CMA; IDH1; IDH2; LAMP2A; autophagy; chaperone-mediated autophagy; p53; reductive carboxylation; α-ketoglutarate
    DOI:  https://doi.org/10.1016/j.devcel.2026.10.009
  8. Cell Signal. 2026 Nov 12. pii: S0898-6568(26)00669-8. [Epub ahead of print] 113009
      The mechanistic target of rapamycin (mTOR) coordinates cell growth, metabolism, protein synthesis, autophagy, and survival by integrating nutrient availability, growth factors, energy status, mechanical cues, and cellular stress. Beyond classical biochemical cascades, mTOR signaling specificity is fundamentally governed by subcellular localization, temporal recruitment, and microenvironmental context. This review synthesizes current insights into the spatial architecture of mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2) across lysosomes, endosomes, plasma-membrane microdomains, organelle contact sites, neuronal processes, the nucleus, and biomolecular condensates. We examine how physical principles-including membrane composition and curvature, molecular confinement, macromolecular crowding, scaffold-mediated multivalent interactions, organelle positioning, mechanical tension, and localized translation-dictate signaling outcomes. Furthermore, we contrast membrane-anchored molecular assemblies with three-dimensional biomolecular condensates, detailing their interplay during stress adaptation. Spatial constraints in specialized cell geometries, such as neuronal compartments and developing tissues, illustrate how identical signaling machinery yields divergent functional outputs under altered diffusion environments. We also evaluate how advances in spatial multi-omics and super-resolution imaging extend these subcellular paradigms to tissue-scale heterogeneity. Finally, we highlight major translational hurdles, including the trade-off between spatial resolution and dynamic temporal tracking in current technologies, as well as the inability of conventional pharmacotherapies to selectively target discrete subcellular mTOR pools. Establishing spatial organization as a primary determinant of mTOR signaling clarifies context-dependent physiological outputs and provides a roadmap for developing next-generation spatially targeted therapeutics.
    Keywords:  Biomolecular condensates; Localized translation; Mechanistic target of rapamycin (mTOR); Membrane microdomains; Metabolic signaling; Spatial regulation; Subcellular compartmentalization
    DOI:  https://doi.org/10.1016/j.cellsig.2026.113009
  9. Cell Rep. 2026 Nov 10. pii: S2211-1247(26)01362-8. [Epub ahead of print]45(11): 118283
      Selective autophagy receptors recognize and recruit harmful intracellular components to autophagosomes for degradation, and their dysfunction is linked to neurodegeneration, metabolic disorders, and cancer. Here, we identified TNFAIP3 interacting protein 1 (TNIP1) as an aggrephagy receptor implicated in neurodegenerative diseases. TNIP1 accumulated at polyubiquitinated protein aggregates upon proteotoxic stress. Genetic depletion of TNIP1 reduced protein aggregate clearance and increased axonal degeneration under proteotoxic stress. Mechanistically, TNIP1 enhanced protein aggregate clearance by assembling aggrephagy receptors, such as SQSTM1/p62 and TAX1BP1, onto protein aggregates. Gene expression analysis revealed that TNIP1 expression levels are reduced in patients with amyotrophic lateral sclerosis (ALS) with TAR DNA-binding protein 43 (TDP-43) inclusion pathology. Additionally, an ALS-associated TNIP1 mutant exhibited impaired association with TDP-43 aggregates and failed to rescue their autophagy-mediated degradation. These findings establish TNIP1 as an aggrephagy receptor and reveal its potential role as a therapeutic target for ALS and other proteinopathies.
    Keywords:  CP: cell biology; CP: neuroscience; TDP-43; TNIP1; aggrephagy; amyotrophic lateral sclerosis; autophagy receptor
    DOI:  https://doi.org/10.1016/j.celrep.2026.118283
  10. Biophys J. 2026 Nov 09. pii: S0006-3495(26)00760-5. [Epub ahead of print]
      Long noncoding RNAs, previously thought to serve no function, have recently been discovered to encode for microproteins that regulate cellular functions. Small regulatory peptide of amino acid response (SPAR) is a microprotein in the lysosome that responds to amino acid availability in the cell. In this study, we investigated the interactions between SPAR and SLC38A9, a lysosomal amino acid transporter and receptor involved in the mechanistic target of rapamycin 1 (mTORC1) pathway. We found that SPAR binds SLC38A9 and inhibits arginine transport in SLC38A9. Moreover, the downstream recruitment of Rag GTPases is also inhibited when SPAR is present in SLC38A9 liposomes. The docking model shows potential interactions between SPAR and SLC38A9. Together, these findings reveal the mechanism of mTORC1 inhibition through microprotein SPAR and illustrate the power of non long coding RNAs in altering cellular functions.
    DOI:  https://doi.org/10.1016/j.bpj.2026.11.009
  11. Nat Cell Biol. 2026 Nov 12.
      Lysophagy is a selective form of autophagy responsible for clearing damaged lysosomes. Although existing models predominantly highlight ubiquitin-dependent mechanisms, here we identify the lysosomal membrane protein TMEM192 as a key ubiquitin-independent receptor for lysophagy. We demonstrate that lysophagy persists in cells even when protein ubiquitination is inhibited or autophagy adaptors are deleted. Following lysosomal damage, the efflux of calcium from lysosomes activates calcineurin, leading to the dephosphorylation of TMEM192 at Ser229. This exposes a latent LC3-interacting region and enables direct recruitment of autophagosomes. Depletion of TMEM192 or blockade of its dephosphorylation severely impairs lysophagy, resulting in the accumulation of damaged lysosomes. In a mouse model of acute hyperuricemic nephropathy, deficiency in TMEM192 exacerbates renal tubular injury. Our findings establish a ubiquitin-independent lysophagy pathway, which holds important implications for understanding and intervening lysosomal-related diseases.
    DOI:  https://doi.org/10.1038/s41556-026-02135-z
  12. Autophagy. 2026 Nov 11. 1-21
      Sepsis constitutes a life-threatening organ dysfunction caused by a dysregulated host response to infection. SESN2 (sestrin 2), an evolutionarily conserved stress-responsive protein, is a pivotal regulator of cellular homeostasis. Here, we identified TRIM13 (tripartite motif-containing 13) as a regulator that modulated the stability of SESN2 at the post-translational level. Specifically, TRIM13 promoted K63-linked ubiquitination of SESN2 with subsequent upregulation of its functional activation. Ubiquitinated SESN2 initiated a selective macroautophagic/autophagic program that facilitated the recruitment of SQSTM1/p62 (sequestosome 1/p62) to mitochondrial surfaces. The enhanced interaction between ubiquitinated SESN2 and the mitophagy receptor FUNDC1 (FUN14 domain-containing 1) at mitochondria-associated membranes (MAMs), facilitated by this modification, potentiated the mitophagic clearance of damaged mitochondria. In addition, it inhibited the interaction between FUNDC1 and RIPK3 (receptor-interacting serine-threonine kinase 3), which in turn ameliorated dysfunction and necroptosis of dendritic cells (DCs) upon sepsis. Thus, our findings establish that TRIM13 mitigates septic responses by activating SESN2-mediated mitophagy through ubiquitination, offering new insights into potential immunomodulatory strategies for sepsis.Abbreviations: AF: AlphaFold; BECN1: beclin 1, autophagy related; CLP: cecal ligation and puncture; co-IP: co-immunoprecipitation; DAMPs: danger/damageassociated molecular patterns; DCs: dendritic cells; DEGs: differentially expressed genes; FUNDC1: FUN14 domain containing 1; IL: interleukin; LPS: lipopolysaccharide; MAMs: mitochondria-associated membranes; MAP1LC3B/LC3B: microtubule associated protein 1 light chain 3 beta; MHC: major histocompatibility complex; MLKL: mixed lineage kinase domain-like; Nec-1: necrostatin-1; PBMCs: peripheral blood mononuclear cells; RIPK3: receptor-interacting serine-threonine kinase 3; SESN2: sestrin 2; SIRT1: sirtuin 1; SQSTM1/p62: sequestosome 1; TEM: transmission electron microscopy; TLR: toll-like receptor; TNF: tumor necrosis factor; TRAF6: TNF receptor-associated factor 6; TRIM13: tripartite motif-containing 13; ULK1: unc-51 like kinase 1; UPR: unfolded protein response; UPS: ubiquitinproteasome system; WT: wild-type.
    Keywords:  Immune dysfunction; mitophagy; sepsis; sestrin 2; tripartite motif-containing 13
    DOI:  https://doi.org/10.1080/15548627.2026.2758017
  13. Science. 2026 Nov 12. 394(6825): eaeh3996
      Lysosomal Ca2+ release from acidic stores is critical for lysosomal function, yet the molecular identity of the Ca2+ uptake conduit has remained elusive. We used a Ca2+-imaging-based genetic screen of the lysosomal membrane proteome to identify TMEM184 family proteins as lysosomal Ca2+ transporters (LyCaTs) essential for Ca2+ uptake and refilling. TMEM184 selectively transported Ca2+ while excluding monovalent cations. Loss of TMEM184B/C depleted lysosomal Ca2+ stores, diminished Ca2+ release, and disrupted lysosomal exocytosis, biogenesis, and membrane repair, thus phenocopying the release channel transient receptor potential mucolipin 1 (TRPML1) deficiency. Moreover, a human TMEM184B mutation associated with a neurodevelopmental disorder compromised lysosomal Ca2+ transport, and Tmem184b-deficient mice exhibited profound motor impairment. Thus, TMEM184 constitutes the long-sought Ca2+ uptake and refilling mechanism that governs lysosomal signaling and homeostasis.
    DOI:  https://doi.org/10.1126/science.aeh3996
  14. Aging Cell. 2026 Nov;pii: e70827. [Epub ahead of print]25(11):
      We demonstrate that the capacity for acute exercise to induce mitophagy in skeletal muscle is impaired in old male mice and corresponds to a loss of mitoAMPKα. We present evidence of age-dependent, exercise-induced phosphorylation of AMPK at S491, which may predispose mitoAMPKα to degradation by the E3-ubiquitin ligase Trim72. Our findings highlight the need to understand how aging alters spatial responses to energetic stressors, like exercise.
    DOI:  https://doi.org/10.1111/acel.70827
  15. Nat Cell Biol. 2026 Nov 12.
      Autophagy, a conserved recycling process, manages intracellular quality control to mitigate stress. To determine the rapid effects of autophagy perturbation, we developed an optogenetic tool to rapidly inhibit autophagy, termed ASAP. Our approach leverages light-induced proteolytic cleavage to selectively inhibit autophagy within 5 min of light exposure, providing a precise and dynamic approach to study autophagy regulation. Proteomic profiling with ASAP revealed the most tightly regulated autophagy substrates along with previously unidentified substrates, including nuclear pore complex proteins. Of note, autophagy regulates quality control of cytoplasmic complexes of nucleoporins via specific LC3-interacting regions, sparing nuclear pore complex proteins embedded in the nuclear envelope. Upon rapid autophagy inhibition, incomplete nucleoporin complexes accumulate and instead of undergoing autophagic degradation, cytoplasmic nucleoporin complexes aggregate in processing bodies (P bodies). Using ASAP, we demonstrate rapid and specific inhibition of autophagy, revealing that nuclear pore complex proteins are tightly regulated autophagy substrates.
    DOI:  https://doi.org/10.1038/s41556-026-02124-2
  16. bioRxiv. 2026 Oct 19. pii: 2026.10.13.758691. [Epub ahead of print]
      Protein aggregate formation can cause cell damage and contribute to tissue pathologies including neurodegeneration. Protein aggregates are normally eliminated by cell-intrinsic mechanisms of lysosomal (autophagic) degradation. However, degradative capacity varies between cell types, raising the possibility that high-capacity cell types, such as macrophages, may contribute to aggregate disposal from the low-capacity cells. Here, we show that cellular protein aggregates are removed by macrophages via trogocytosis - a partial engulfment of the target cells. Lysosomal stress upon protein aggregate accumulation promotes cell surface expression of the transmembrane isoform of the macrophage growth factor CSF1 (tmCSF1), which is detected by macrophages through the CSF1 receptor to drive trogocytosis. Insufficient or impaired degradation of protein aggregates in lysosomes results in their transport along microtubules to the plasma membrane where they physically associate with tmCSF1. This enables macrophages to specifically trogocytose protein aggregates. These findings reveal a protein homeostasis system that eliminates protein aggregates in a non-cell-autonomous manner.
    DOI:  https://doi.org/10.64898/2026.10.13.758691
  17. iScience. 2026 Nov 20. 29(11): 118008
      Little is known about the mechanism for maintaining quality of the proteins in young and growing muscles despite that they likely face constant challenges to the protein quality control (PQC). Here, we explored the role(s) of TGF-β/activin pathway in the PQC of Drosophila body wall muscle that grows rapidly during larval stage. We find that the TGF-β/activin pathway positively regulates the proteasomal activity in body wall muscle by promoting the expression of proteasomal subunits. The proteasomal activity is then necessary for proper assembly of sarcomeres and for targeting glutamate receptors to the synapse. In contrast, TGF-β/activin pathway represses autophagy through the suppression of Atg1 expression. Consequently, autophagy is elevated in TGF-β/activin signaling-blocked muscle which in turn has a protective role against the threats to PQC. Together, these results demonstrate a multifaceted role for the TGF-β/activin pathway in regulating PQC of young and growing muscle in Drosophila.
    Keywords:  TGF beta; activin; autophagy; muscle proteostasis; proteasome; protein quality control; sarcomere
    DOI:  https://doi.org/10.1016/j.isci.2026.118008
  18. Anim Cells Syst (Seoul). 2026 ;30(1): 644-656
      Mitochondrial dysfunction and impaired mitophagy are increasingly recognized as central contributors to pathogenesis of amyotrophic lateral sclerosis (ALS). In this study, we identified OGS-MA114 (C₂₃H₁₉ClN₄O₃S), as a compound that activates mitophagy through a bioactive chemical library screen in SH-SY5Y cells. OGS-MA114 significantly enhanced autophagic and mitophagic flux, increased Ser65-phosphorylated ubiquitin levels, and promoted Parkin recruitment to damaged mitochondria, indicating activation of the PINK1/Parkin pathway. In SH-SY5Y cells expressing the ALS-associated FUSP525L mutant, OGS-MA114 restored mitochondrial membrane potential, reduced cleaved caspase-3 levels, and improved cell viability under mitochondrial stress conditions. Furthermore, in a transgenic zebrafish model expressing mutant FUSR521C, OGS-MA114 significantly improved locomotor activity and survival while reducing cell death in the spinal cord. These findings suggest that OGS-MA114 ameliorates ALS-associated pathological phenotypes by enhancing PINK1-dependent mitophagy. Thus, pharmacological modulation of mitophagy may provide a useful basis for further investigation of ALS and -related neurodegenerative disorders.
    Keywords:  FUSP525L; OGS-MA114; amyotrophic lateral sclerosis; mitophagy; neuroprotection
    DOI:  https://doi.org/10.1080/19768354.2026.2736980
  19. FASEB J. 2026 Nov 30. pii: e72474. [Epub ahead of print]40(22):
      Nuclear Dbf2-related kinase 1 (NDR1), a Hippo-pathway protein kinase, regulates proliferation, apoptosis, and differentiation, but its role in bone homeostasis remains unclear. Here, we identified a novel role for NDR1 in maintaining physiological bone homeostasis by regulating osteoblast differentiation, but not osteoclastogenesis. Using NDR1 global knockout mice, primary osteoblast cultures, transcriptomics, and biochemical profiling, we demonstrated that deletion of NDR1 leads to decreased bone mass and impaired osteogenic differentiation capacity. Transcriptomic profiling revealed a significant enrichment of the PI3K-AKT signaling pathway in NDR1-deficient osteoblasts, indicating a potential mechanistic link. Moreover, we found that NDR1 physically interacts with Beclin-1 in osteoblasts, and NDR1 deletion was accompanied by downregulated Beclin-1 expression and reduced autophagic activity during osteoblast differentiation. Notably, pharmacological activation of PI3K-AKT with SC79 or enhancement of autophagy with rapamycin each partially rescued the osteogenic defects and bone loss in NDR1-KO mice. Together, our findings establish NDR1 as a novel regulator of bone formation and suggest its therapeutic potential for treating bone-related disorders such as osteoporosis.
    Keywords:  Beclin‐1; NDR1; PI3K‐AKT pathway; autophagy; bone remodeling; osteoblast
    DOI:  https://doi.org/10.1096/fj.202600410RR
  20. Biosci Biotechnol Biochem. 2026 Nov 11. pii: zbag145. [Epub ahead of print]
      Nuclear protein quality control (PQC) is essential for maintaining protein homeostasis in long-lived, non-mitotic cells, and its impairment contributes to neurological disorders. Misfolded nuclear proteins are sequestered into intranuclear quality control compartments (INQs), but the mechanisms underlying INQ clearance remain poorly understood. Using an aggregation-prone nuclear protein as a model substrate, we investigated the pathways responsible for INQ clearance in budding yeast. We found that INQ-containing nuclear regions protrude toward the vacuole at nucleus-vacuole junctions (NVJs), accompanied by ESCRT-dependent NVJ deformation. INQ-associated proteins were degraded through both the ubiquitin-proteasome system (UPS) and nucleophagy, with the UPS serving as the predominant clearance pathway. Our results suggest that macronucleophagy contributes to INQ protein degradation to some extent. The contribution of micronucleophagy appears limited. Efficient nucleophagic degradation of INQ also required ESCRT function. These findings reveal that INQ clearance involves complementary actions of the UPS and nucleophagy, providing mechanisms for maintaining nuclear proteostasis and integrity.
    Keywords:  ESCRT; INQ; autophagy; nuclear protein quality control; proteasome
    DOI:  https://doi.org/10.1093/bbb/zbag145
  21. Cell Death Dis. 2026 Aug 18. pii: 963. [Epub ahead of print]17(1):
      Mitochondria play a pivotal role in spermatogenesis and male fertility, in which the selective autophagic degradation of mitochondria (mitophagy) constitutes a key process. In this study, we identify mitochondrial carrier homolog 2 (MTCH2) as a novel and critical regulator of germ cell mitophagy. Localized to the mitochondrial outer membrane (OMM), MTCH2 directly interacts with the core autophagy protein BECN1, thereby inhibiting autophagic flux and specifically suppressing mitophagy. Germ cell-specific heterozygous deletion of Mtch2 was sufficient to cause profound spermatogenic defects, including disorganized seminiferous tubules, vacuolization, mitochondrial sheath abnormalities, and significantly impaired sperm fertilization capacity. Transcriptomic profiling revealed that MTCH2 deficiency dysregulates pathways central to mitochondrial function and programmed cell death. Importantly, augmenting autophagy ameliorated mitochondrial dysfunction induced by MTCH2 deficiency, as characterized by impaired mitochondrial membrane potential, elevated mitochondrial reactive oxygen species (mtROS) production and cellular ROS levels. Collectively, our findings establish MTCH2 as an essential negative regulator of mitophagy that partners with BECN1 to maintain mitochondrial homeostasis, thereby ensuring normal spermatogenesis and male fertility.
    DOI:  https://doi.org/10.1038/s41419-026-09165-3
  22. medRxiv. 2026 Oct 15. pii: 2026.10.13.26365182. [Epub ahead of print]
      Genetic regulation of neurodevelopmental disorders that impair brain development and social interaction is complex and poorly understood. Although emerging evidence suggests a link between neurodevelopmental disorders and autophagy deficits, congenital autophagy gene disorders are rare in humans, and underlying molecular mechanisms remain unknown. Here we demonstrate that the autophagy protein BECN1 is a regulator of neuronal and social development in vertebrate species. We identify rare deleterious biallelic BECN1 variants that cause neurodevelopmental disorders in two unrelated families. Becn1 disruption also causes neuronal and social developmental defects in mouse and zebrafish models. BECN1 serves as an adaptor to recruit Arc to the E3 ubiquitin ligase UBE3A for polyubiquitination and degradation, thereby maintaining postsynaptic AMPA receptor (AMPAR) stability, AMPAR-mediated excitatory neurotransmission, and normal social interaction. Thus, our study illustrates new biology and a non-canonical mechanism by which BECN1 regulates neurodevelopment in humans, mice and zebrafish, via a crosstalk with the ubiquitin-proteasomal machinery.
    DOI:  https://doi.org/10.64898/2026.10.13.26365182
  23. Cell Death Discov. 2026 Aug 14. pii: 451. [Epub ahead of print]12(1):
      Mutations in Fused in Sarcoma (FUS), an RNA binding protein, cause Amyotrophic Lateral Sclerosis (ALS). ALS is an aggressive neurodegenerative disease resulting in motor neuron degeneration. Defects in synaptic integrity precede neuronal loss in ALS, but the mechanisms responsible for these early synaptic defects are unclear. To investigate early synaptic defects associated with ALS, we expressed an ALS-linked variant of human FUS in adult motor neurons and assessed synaptic pathology at the neuromuscular junction (NMJ). Here, we highlight the accumulation of FUS-positive aggregates at synaptic terminals and subsequent reduction in microtubule stability. Autophagy induction via expression of Rab1 or Fragile-X Mental Retardation Protein 1 (FMR1), or treatment with rapamycin reduces aggregate formation and restores synaptic structure and function. These findings reveal the utility of inducing autophagy to address early synaptic dysfunction in an ALS model and demonstrate a potential therapeutic target to preventing later stages of disease progression.Teaser Maintaining synaptic integrity protects motor neurons in a model of ALS.
    DOI:  https://doi.org/10.1038/s41420-026-03286-6
  24. Front Neurol. 2026 ;17 1922997
      There is mounting evidence that dietary habits are strongly correlated with cerebrovascular diseases and dementia, but the precise mechanism remains unclear how a salt-rich diet adversely affects the brain. Here, 12-month-old mice were fed a high-salt diet (HSD) for 2 months, and we observed salt-induced cognitive deficits in mice. The short-term HSD increased mitophagy-associated markers (PINK1, Parkin, and LC3-II) and decreased SQSTM1/p62, consistent with a compensatory mitophagy response that was insufficient to prevent cognitive decline. Neuro-2a cells were cultured in normal medium, NaCl medium (40 mM) or NaCl (40 mM) + CCCP group (20 μM) medium for 24 h, respectively. Short-term HSD feeding impaired learning and memory and increased amyloid-β (Aβ) burden, in parallel with altered PINK1/Parkin-associated mitophagy markers. These findings link a salt-rich diet to cognitive dysfunction, and suggest that enhancing PINK1/Parkin-mediated mitophagy may counteract the harmful effects of HSD on the brain. Therefore, the PINK1/Parkin mitophagy may be a potential target for combating the harmful effects on the brain caused by HSD or other diseases related to mitophagy.
    Keywords:  amyloid-β; behavior; cognitive impairment; high-salt diet; mitophagy
    DOI:  https://doi.org/10.3389/fneur.2026.1922997
  25. Biochem Soc Trans. 2026 Nov 25. 54(11): 1607-1621
      Classical small-molecule drugs have traditionally relied on an occupancy-driven paradigm that requires tight and sustained binding to a well-defined pocket on the target protein. Targeted protein degradation (TPD) approaches have emerged to overcome the limitations of traditional pharmacology to promote the selective degradation of disease-associated proteins, harnessing the central proteostasis pathways in eukaryotic cells: the ubiquitin proteasome system and the autophagy-lysosomal machinery. Thus, TPD exploits the idea of reprogramming cellular proteostasis for therapeutic benefits, dictating the fate of the target protein by means of degrader molecules that induce proximity between a target protein and components of the degradation machineries. The present review gives an overview of the molecular mechanisms of cellular proteostasis and how they are exploited for drug discovery purposes through TPD strategies. We describe some of the most explored degrader modalities, such as molecular glues, proteolysis targeting chimeras, and lysosomal targeting chimeras, as well as new modalities of degraders, highlighting their major advantages and limitations, and discuss the challenges associated with their development, including ligand identification, target degradability, or the possibility for their rational design. Furthermore, we consider recent advances in the design of these degraders to potentially address those limitations. Together, these insights established TPD as a transformative pharmacological modality that revolutionized drug discovery campaigns since it expands the druggable proteome, offering numerous advantages over traditional drugs.
    Keywords:  drug discovery and design; pharmacology; protein-protein interactions; proteostasis; ubiquitin ligases; ubiquitin proteasome system
    DOI:  https://doi.org/10.1042/BST20250441